SARS-CoV-2 S protein subunit-trimer vaccine (Clover Biopharmaceuticals)

N/A

Report date: 2025/01/26 16:18:19

Base Information

Drug NameSARS-CoV-2 S protein subunit-trimer vaccine (Clover Biopharmaceuticals)
Drug Alias NamePan SARS-CoV-2 vaccine (Clover Biopharmaceuticals)S-Trimer vaccine (Clover Biopharmaceuticals)SARS-CoV-2 S-trimer (Clover Biopharmaceuticals)protein-based vaccine (Clover Biopharmaceuticals)XBB-adapted SARS-CoV-2 vaccine (Clover Biopharmaceuticals)
ClassificationVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineBiologics > Protein drugs > Recombinant protein > Fusion proteinVaccines > Application > Prophylactic vaccine
Mechanisms of ActionCoronavirus spike glycoprotein modulators
TargetsCoronavirus spike glycoprotein
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesClover Biopharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesClover Biopharmaceuticals Ltd
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A